Design, synthesis and biological activity evaluation of regioisomeric spiro-(indoline-isoxazolidines) in the inhibition of TNF-α-induced ICAM-1 expression on human endothelial cells

Malhotra, Shashwat ; Balwani, Sakshi ; Dhawan, Ashish ; Raunak, * ; Kumar, Yogesh ; Singh, Brajendra K. ; Olsen, Carl E. ; Prasad, Ashok K. ; Parmar, Virinder S. ; Ghosh, Balaram (2012) Design, synthesis and biological activity evaluation of regioisomeric spiro-(indoline-isoxazolidines) in the inhibition of TNF-α-induced ICAM-1 expression on human endothelial cells MedChemComm, 3 (12). pp. 1536-1547. ISSN 2040-2503

Full text not available from this repository.

Official URL: http://pubs.rsc.org/en/content/articlelanding/2012...

Related URL: http://dx.doi.org/10.1039/C2MD20216F

Abstract

Different regioisomeric spiro-(indoline-isoxazolidines) have been synthesized by the microwave mediated cycloaddition reaction between ethyl(5-fluoro-3-indolylidene)-acetate/ethyl(3-indolylidene)-acetate and the substituted α,N-diphenylnitrones. These compounds were screened for their anti-inflammatory activities through inhibition of TNF-α-induced ICAM-1 expression on human endothelial cells. Spiro-(indoline-isoxazolidine) 9p was found to be the most potent compound in inhibiting the ICAM-1 expression. Furthermore, compound 9p significantly inhibited the adhesion of neutrophils to the endothelium in a concentration-dependent manner and also blocked the translocation of NF-κBp65 subunit from the cytoplasm to the nucleus. We believe that compound 9p could be useful in developing better anti-inflammatory molecules for various inflammatory diseases where NF-κB plays a key role.

Item Type:Article
Source:Copyright of this article belongs to Royal Society of Chemistry.
ID Code:96391
Deposited On:18 Dec 2012 07:02
Last Modified:18 Dec 2012 07:02

Repository Staff Only: item control page